Industry

ATLANTA–(BUSINESS WIRE)–Regional Health Properties, Inc. (“Regional”) (OTCQB: RHEP) (OTCQB: RHEPA) and SunLink Health Systems, Inc. (“SunLink”) (NYSE American: SSY) jointly announced today that, at special meetings of their respective shareholders each held on August 4, 2025, Regional shareholders and SunLink shareholders approved the merger of SunLink with and into Regional, with Regional as the surviving … [Read more…]

BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conference call on Thursday, August 7, 2025, at 4:30 p.m. E.T., to discuss its second quarter 2025 financial results. Quanterix will issue a press release regarding its second quarter 2025 financial results prior … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Literature Searching in Drug Safety Training Course” training has been added to ResearchAndMarkets.com’s offering. This comprehensive two-day course provides an in-depth understanding of literature searching in drug safety, focusing on regulatory requirements, literature search criteria, and the interpretation of safety data from published sources. Participants will explore best practices for conducting literature searches, … [Read more…]

INDIANAPOLIS–(BUSINESS WIRE)–HKW, a middle-market private equity firm focused on growth companies, has partnered with the Cherubini family to recapitalize AliMed Inc. (“AliMed”). AliMed is a national provider of branded medical products headquartered in Dedham, MA. Founded in 1970, AliMed serves over 15,000 acute and non-acute care facilities, including hospitals, surgery centers, nursing homes and long-term … [Read more…]

DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for diseases with high unmet need, today announced that it will publish financial results for the second quarter 2025 and provide a business update on August 7, 2025. About … [Read more…]

Establishes First Truly Global Early-Phase Clinical Trial Network BRISBANE, Australia & LONDON–(BUSINESS WIRE)–Nucleus Network, a global leader in early phase clinical research, today announced the acquisition of Hammersmith Medicines Research (HMR), one of the United Kingdom’s most respected early phase clinical trial organisations. This milestone marks a significant step in Nucleus Network’s global growth, establishing … [Read more…]

MARSEILLE, France–(BUSINESS WIRE)–Regulatory news: Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or “AMF”) General Regulation, Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) releases its total number of shares outstanding as well … [Read more…]

TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Joe Hogan, Align Technology president and CEO, has personally purchased approximately $1 million of … [Read more…]

Topline results expected H2 2025 REDWOOD CITY, Calif.–(BUSINESS WIRE)–Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed the last patient, last visit in its ongoing Phase 2 clinical trial (NCT05561751) evaluating the safety and efficacy of GPC-100 (burixafor) in combination with propranolol and G-CSF in multiple … [Read more…]

CINCINNATI–(BUSINESS WIRE)–Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed’s existing share repurchase program. These shares repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has … [Read more…]